Stock screener

NKTR

Conviction 44HealthcareScan · Thu, Sep 24, 2026
Bullish harami

Nektar Therapeutics (NKTR) closed at $59.33 (+2.89%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is below its 50-day and below its 200-day moving average. RSI(14) 30, RS Rating 65, -40.9% from its 52-week high, +36.6% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

NKTR$59.33+2.89%
ResistanceSupportVol 14Insider sell
63 bars
2
Vol MA14 1.41M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
NEKTAR THERAPEUTICSPHARMACEUTICAL PREPARATIONSwww.nektar.com ↗
Price59.33
Change+2.89%
Gap+0.60%
Rel volume2.31×
Avg volume1.12M
Avg $ vol74.33M
SMA 2069.27
SMA 5071.07
SMA 20065.44
Price vs 50-16.53%
Price vs 200-9.34%
MA stackmixed
50/200 cross—
Supertrenddown · 69.34
RSI (14)30
MACD hist-1.40
MACD cross—
Stoch %K / %D14 / 9
ADX (14)17
+DI / −DI14 / 33
RSI divergence—
MACD divergenceBearish
ATR %5.90%
ADR %4.88%
52w high100.35
52w low35.12
From 52w high-40.88%
Above 52w low+68.92%
New 52w highNo
SqueezeOff
Bollinger width29.37%
%B0.01
Donchian pos14.34%
Donchian high77.76
Donchian low56.24
AVWAP (52w high)72.20
vs AVWAP high-17.83%
AVWAP (52w low)70.14
vs AVWAP low-15.42%
OBV trendDown
Chaikin MF (20)-0.34
Today vs 20d2.31×
Avg vol (14d)1.41M
Avg vol (20d)1.12M
Avg $ vol (20d)74.33M
Market cap2.03B
RS Rating65 / 99
RS 3m (vs SPY)-8.85%
RS 6m (vs SPY)-34.51%
RS line new highNo
Trend template3/8
Technical rank17.2
1 week-13.22%
1 month-20.86%
3 months-4.36%
6 months-17.70%
1 year-0.46%
YTD+36.63%
P/E-12.35
P/B2.24
P/S36.67
P/FCF-9.71
EPS-9.73
Div yield—
ROE-18.17%
ROA-14.98%
Debt/Eq0.15
Current10.42
EV/EBITDA-15.59
Gross margin1.13%
Net margin-297.07%
Rev growth-43.89%
EPS growth-37.92%
Price target139.14
Target upside134.54%
Analyst ratingBuy
Institutional109.84%
Ent. value2.12B
Revenue10.13M
Net income-40.62M
Gross profit—
Free cash flow-208.68M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out33.79M
Employees63
ListedTue, May 3, 1994
Free float28.9M
Float %97.4%
Short interest6.07M
Days to cover11.4d
Short volume54.3%
Squeeze score90 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.23 vs −$2.06
Last surprise+40.3% beat
Setup gradeD
Conviction44 / 100
Pattern quality—
Tech rank17.2 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NKTR

All disclosures →
No recent disclosed trades by Congress in NKTR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NKTR · open-market 8 sells

InsiderSideShares
ROBIN HOWARD W
President & CEO · Common Stock · 2026-08-18
Sell418
Zalevsky Jonathan
Chief R&D Officer · Common Stock · 2026-08-18
Sell186
ROBIN HOWARD W
President & CEO · Common Stock · 2026-06-17
Sell5.5K
ROBIN HOWARD W
President & CEO · Common Stock · 2026-06-17
Sell4.5K
ROBIN HOWARD W
President & CEO · Common Stock · 2026-06-16
Sell5.3K
ROBIN HOWARD W
President & CEO · Common Stock · 2026-06-16
Sell4.7K
Zalevsky Jonathan
Chief R&D Officer · Common Stock · 2026-05-19
Sell199
ROBIN HOWARD W
President & CEO · Common Stock · 2026-05-19
Other—
ROBIN HOWARD W
President & CEO · Common Stock · 2026-05-19
Sell444

SEC filings

EDGAR filings in NKTR · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.